Remove about-us
article thumbnail

What the noses of mice can tell us about the inheritance of trauma

STAT

In the final year of World War II, Nazi troops starved the Netherlands in a brutal event known as the Dutch Hunger Winter. Some 20,000 people died and millions more suffered from this man-made famine.

141
141
article thumbnail

What the brains of song birds can teach us about human stuttering

STAT

A symphony of synapses fires every time a songbird sings. For Erich Jarvis, a neurobiologist at Rockefeller University, the neural pathways he finds particularly interesting inside a birds’ brain are those that enable the bird to make new sounds from listening to their environment.

138
138
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What The NAPLEX 2022 Pass Rate Tells Us About 2023

Med Ed 101

Just looking at the California Board of Pharmacy […] The post What The NAPLEX 2022 Pass Rate Tells Us About 2023 appeared first on Med Ed 101. The pass rate that year was an indicator that the NAPLEX was not very difficult. That is not the case anymore.

98
article thumbnail

Looking Back to Go Forward: What 2023 Has Taught Us About Biosimilar Adoption

Pharmacy Times

In 2024, there is an urgent need for policies that will accelerate biosimilar use to achieve lower system-wide health care costs.

132
132
article thumbnail

'Podnosis': Is virtual-first care here to stay, and what can be done about skyrocketing US drug prices

Fierce Healthcare

Podnosis': Is virtual-first care here to stay, and what can be done about skyrocketing US drug prices. Tue, 11/29/2022 - 12:35.

98
article thumbnail

European Generic Medication Shortages Raise Concerns About US Drug Supply

Pharmacy Times

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

139
139
article thumbnail

Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO

Fierce Pharma

Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO fkansteiner Tue, 03/21/2023 - 09:41

52